Gene · 8081
Papers1,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene and Cellular Therapies for Leukodystrophies. | Pharmaceutics | 2023 | 38004502 | PubTator, text mining | PubMed |
| An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines. | Biomolecules | 2023 | 38002247 | PubTator, text mining | PubMed |
| Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer. | Cancers (Basel) | 2023 | 37958464 | PubTator, text mining | PubMed |
| Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates. | NPJ Vaccines | 2023 | 37925544 | PubTator, text mining | PubMed |
| The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. | Front Immunol | 2023 | 37901229 | PubTator, text mining | PubMed |
| Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector. | Sci Rep | 2023 | 37898650 | PubTator, text mining | PubMed |
| Structure-Dependent Mechanism of Organophosphate Release from Albumin and Butyrylcholinesterase Adducts When Exposed to Fluoride Ion: A Comprehensive In Silico Study. | Int J Mol Sci | 2023 | 37834267 | PubTator, text mining | PubMed |
| Construction and application of adenoviral vectors. | Mol Ther Nucleic Acids | 2023 | 37808925 | PubTator, text mining | PubMed |
| Structure-based design of nanobodies that inhibit seeding of Alzheimer's patient-extracted tau fibrils. | Proc Natl Acad Sci U S A | 2023 | 37801475 | PubTator, text mining | PubMed |
| The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model. | Res Sq | 2023 | 37790556 | PubTator, text mining | PubMed |
| Innate Immune Response to Viral Vectors in Gene Therapy. | Viruses | 2023 | 37766208 | PubTator, text mining | PubMed |
| Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre-Fusion Spike Glycoproteins Protects Non-Human Primates against SARS-CoV-2 Infection. | Vaccines (Basel) | 2023 | 37766104 | PubTator, text mining | PubMed |
| Generating and measuring effective vaccine-elicited HIV-specific CD8 + T cell responses. | Curr Opin HIV AIDS | 2023 | 37751362 | PubTator, text mining | PubMed |
| Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer's disease tau. | Cell Biosci | 2023 | 37723591 | PubTator, text mining | PubMed |
| A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma. | PLoS One | 2023 | 37713401 | PubTator, text mining | PubMed |
| Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses. | PLoS Pathog | 2023 | 37703278 | PubTator, text mining | PubMed |
| Anticancer Activity of Measles-Mumps-Rubella MMR Vaccine Viruses against Glioblastoma. | Cancers (Basel) | 2023 | 37686579 | PubTator, text mining | PubMed |
| AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis. | Cells | 2023 | 37681859 | PubTator, text mining | PubMed |
| Novel cationic cryptides in Penaeus vannamei demonstrate antimicrobial and anti-cancer activities. | Sci Rep | 2023 | 37673929 | PubTator, text mining | PubMed |
| Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. | Cancer Gene Ther | 2023 | 37666898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8081/papers?page=3